Who owns Ngm Biopharmaceuticals Inc?
- Ticker: NGM
- CUSIP Number: 62921n105
Tip: Access positions for across all investors
Analyze quarterly positions in Ngm Biopharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ngm Biopharmaceuticals stock
Who bought or sold Ngm Biopharmaceuticals Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Column Group | 18M | $16M | 0% | Dec 2023 |
|
| Vanguard Group | 2.8M | $2.4M | 0% | Dec 2023 |
|
| EcoR1 Capital | 2.4M | $2.0M | -63% | Dec 2023 |
|
| Millennium Management | 1.3M | $1.1M | 498% | Dec 2023 |
|
| Euclidean Capital | 992k | $852k | 0% | Dec 2023 |
|
| Two Sigma Advisers | 587k | $504k | 24% | Dec 2023 |
|
| Jacobs Levy Equity Management | 556k | $478k | 0% | Dec 2023 |
|
| Two Sigma Investments | 491k | $421k | 21% | Dec 2023 |
|
| Federated Investors | 345k | $297k | -41% | Dec 2023 |
|
| GSA Capital Partners | 335k | $287k | 57% | Dec 2023 |
|
| D. E. Shaw & Co | 308k | $265k | -4% | Dec 2023 |
|
| Charles Schwab Investment Management | 279k | $239k | 1% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 221k | $190k | 155% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 213k | $183k | 100% | Dec 2023 |
|
| Squarepoint Ops | 213k | $183k | 52% | Dec 2023 |
|
| Exchange Traded Concepts | 186k | $296k | 74% | Mar 2024 |
|
| Dimensional Fund Advisors | 155k | $133k | -26% | Dec 2023 |
|
| Bank of New York Mellon | 139k | $120k | 0% | Dec 2023 |
|
| Man Group | 120k | $103k | -26% | Dec 2023 |
|
| Goldman Sachs Group | 111k | $95k | -60% | Dec 2023 |
|
| Barclays | 91k | $78k | 135% | Dec 2023 |
|
| Citadel Advisors | 73k | $62k | -56% | Dec 2023 |
|
| Hennion & Walsh Asset Management | 71k | $112k | 7% | Mar 2024 |
|
| State of Wisconsin Investment Board | 69k | $59k | -41% | Dec 2023 |
|
| Rhumbline Advisers | 65k | $56k | 0% | Dec 2023 |
|
| Alliancebernstein | 64k | $55k | -6% | Dec 2023 |
|
| Mackenzie Financial | 63k | $54k | 40% | Dec 2023 |
|
| Jane Street | 59k | $51k | -17% | Dec 2023 |
|
| Bank of America Corporation | 57k | $49k | -49% | Dec 2023 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 49k | $42k | 0% | Dec 2023 |
|
| Ohio Pers | 48k | $42k | 0% | Dec 2023 |
|
| UBS Group | 47k | $41k | 111% | Dec 2023 |
|
| Russell Investments | 44k | $38k | -65% | Dec 2023 |
|
| Jpmorgan Chase & Co | 28k | $24k | -98% | Dec 2023 |
|
| Clarius | 27k | $43k | 1% | Mar 2024 |
|
| Tudor Investment Corporation | 25k | $22k | 0% | Dec 2023 |
|
| SG Americas Securities | 24k | $20k | 8% | Dec 2023 |
|
| Carson Advisory | 23k | $19k | 42% | Dec 2023 |
|
| American International | 22k | $19k | 0% | Dec 2023 |
|
| Jasper Ridge Partners | 19k | $17k | -94% | Dec 2023 |
|
| Principal Financial Group | 19k | $16k | -8% | Dec 2023 |
|
| Wells Fargo & Company | 14k | $12k | 24% | Dec 2023 |
|
| Royal Bank of Canada | 13k | $11k | 40% | Dec 2023 |
|
| Hrt Financial | 13k | $11k | 100% | Dec 2023 |
|
| Us Bancorp | 13k | $11k | 100% | Dec 2023 |
|
| Walleye Trading Advisors | 12k | $11k | -92% | Dec 2023 |
|
| Florida State Board of Administration | 11k | $9.7k | 100% | Dec 2023 |
|
| New York State Common Retirement Fund | 10k | $9.0k | 0% | Dec 2023 |
|
| T. Rowe Price Associates | 10k | $9.0k | -77% | Dec 2023 |
|
| Citigroup | 7.4k | $6.3k | 600% | Dec 2023 |
|
| Cutler | 3.4k | $4.4k | 10% | Mar 2024 |
|
| Summit Investment Advisors | 3.1k | $2.7k | 0% | Dec 2023 |
|
| Legal & General Group | 3.0k | $2.6k | 0% | Dec 2023 |
|
| Amalgamated Bank | 1.4k | $2.0k | -63% | Mar 2024 |
|
| Capital Advisors | 777.00 | $999.999000 | 100% | Mar 2024 |
|
| GAMMA Investing | 346.00 | $550.001600 | 0% | Mar 2024 |
|
| Simplex Trading | 147.00 | $0 | -59% | Dec 2023 |
|
| NISA Investment Advisors | 75.00 | $63.997500 | -93% | Dec 2023 |
|
| Covestor | 65.00 | $0 | 261% | Dec 2023 |
|
| CWM | 6.00 | $0 | -99% | Mar 2024 |
|
Who sold out of Ngm Biopharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Boxer Capital | Sep 2023 | 500k | $535k |
| Parkwood | Sep 2023 | 68k | $73k |
| CornerCap Investment Counsel | Sep 2023 | 51k | $55k |
| Algert Coldiron Investors | Sep 2023 | 37k | $40k |
| Cubist Systematic Strategies | Sep 2023 | 34k | $37k |
| Point72 Middle East FZE | Sep 2023 | 29k | $31k |
| Raymond James & Associates | Dec 2023 | 21k | $18k |
| Franklin Resources | Sep 2023 | 14k | $15k |
| Virtu Financial | Sep 2023 | 11k | $12k |
| Steward Partners Investment Advisory | Sep 2023 | 4.1k | $4.4k |
| China Universal Asset Management | Sep 2023 | 2.1k | $2.0k |
| Pnc Financial Services | Sep 2023 | 512.00 | $547.993600 |
| Daiwa Securities Group | Sep 2023 | 265.00 | $0 |
| Glassman Wealth Services | Sep 2023 | 92.00 | $97.998400 |